The Patient Voice in Drug Development: From Anger to Activism to Established Interaction
This talk shows the history of AIDS activism, its impact on drug development, research and regulation to the EUPATI IMI consortium where patients are systematically trained and prepared to provide a meaningful contribution to all relevant stakeholders.
We are delighted to welcome David H.-U. Haerry, Positive Council Switzerland, European AIDS Treatment Group.
| Date: | 25 April 2018 |
|---|---|
| Time: | 17.00 h to 18.00 h |
| Location: | HS 9 |
The Patient Voice in Drug Development: From Anger to Activism to Established Interaction
The patients voice in research and drug development was heard for the first time in the 1980s when gay men in the United States were all of a sudden struck by a frightening epidemic called AIDS. As these men were just in the early days of a large civic liberation movement, they had the tools and methods ready to get themselves heard in this unprecedented health challenge.
Lecture Series Spring 2018: The Patient's Voice in Drug Development
In this lecture series, professionals from industries, adademia and patient organizations will share their visions how the patient perspective can become an integral part of the drug development process, and how this relates to public interests, regulatory requirements, the law and international initiatives.
